Swiss National Bank lifted its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.0% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 3,387,203 shares of the pharmacy operator’s stock after acquiring an additional 35,100 shares during the period. Swiss National Bank owned approximately 335,516.12% of Walgreens Boots Alliance worth $261,560,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of WBA. Oarsman Capital Inc. raised its stake in shares of Walgreens Boots Alliance by 23.0% during the 1st quarter. Oarsman Capital Inc. now owns 39,429 shares of the pharmacy operator’s stock worth $3,275,000 after buying an additional 7,383 shares during the period. Hyman Charles D raised its stake in shares of Walgreens Boots Alliance by 0.3% during the 1st quarter. Hyman Charles D now owns 110,158 shares of the pharmacy operator’s stock worth $9,149,000 after buying an additional 277 shares during the period. Boston Private Wealth LLC raised its stake in shares of Walgreens Boots Alliance by 3.3% during the 1st quarter. Boston Private Wealth LLC now owns 173,152 shares of the pharmacy operator’s stock worth $14,380,000 after buying an additional 5,550 shares during the period. BB&T Securities LLC raised its stake in Walgreens Boots Alliance by 24.3% in the 1st quarter. BB&T Securities LLC now owns 73,390 shares of the pharmacy operator’s stock valued at $6,095,000 after purchasing an additional 14,324 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. raised its stake in Walgreens Boots Alliance by 113.9% in the 1st quarter. ZWJ Investment Counsel Inc. now owns 11,638 shares of the pharmacy operator’s stock valued at $967,000 after purchasing an additional 6,197 shares during the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.
WBA has been the subject of several recent research reports. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Jefferies Group reissued a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Needham & Company LLC reissued a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. Royal Bank of Canada initiated coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Finally, Raymond James Financial reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. Walgreens Boots Alliance currently has an average rating of “Buy” and an average target price of $86.89.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same period last year, the company earned $1.07 EPS. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.
Walgreens Boots Alliance declared that its board has authorized a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s management believes its stock is undervalued.
In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction dated Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.com-unik.info/2017/12/23/swiss-national-bank-purchases-35100-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.